Evidence map›Paper›PMID 37675373›Full record

ArticleFrontiers in nephrology2023

Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data.

Juntao Duan, Hanmo Li, Xiaoran Ma, Hanjie Zhang, Rachel Lasky, Caitlin K Monaghan, Sheetal Chaudhuri, Len A Usvyat, Mengyang Gu, Wensheng Guo and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Frontiers in nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Juntao DuanDepartment of Statistics and Applied Probability, University of California, Santa Barbara, CA, United States.
Hanmo LiDepartment of Statistics and Applied Probability, University of California, Santa Barbara, CA, United States.
Xiaoran MaDepartment of Statistics and Applied Probability, University of California, Santa Barbara, CA, United States.
Hanjie ZhangRenal Research Institute, New York NY, United States.
Rachel LaskyFresenius Medical Care, Global Medical Office, Waltham, MA, United States.
Caitlin K MonaghanFresenius Medical Care, Global Medical Office, Waltham, MA, United States.
Sheetal ChaudhuriFresenius Medical Care, Global Medical Office, Waltham, MA, United States.
Len A UsvyatFresenius Medical Care, Global Medical Office, Waltham, MA, United States.
Mengyang GuDepartment of Statistics and Applied Probability, University of California, Santa Barbara, CA, United States.
Wensheng GuoDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, United States.
Peter KotankoRenal Research Institute, New York NY, United States.
Yuedong WangDepartment of Statistics and Applied Probability, University of California, Santa Barbara, CA, United States.
University of California, Santa Barbara · USFresenius Medical Care North America (United States) · USFresenius Medical Care (United States) · USIcahn School of Medicine at Mount Sinai · USRenal Research Institute · USUniversity of Pennsylvania · US

Funding

Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sourcesR01DK130067 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI GUO, WENSHENG, KOTANKO, PETER · 2021 to 2023
$2.0M
NIDDK NIH HHS R01 DK130067
6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has created more devastation among dialysis patients than among the general population. Patient-level prediction models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are crucial for the early identification of patients to prevent and mitigate outbreaks within dialysis clinics. As the COVID-19 pandemic evolves, it is unclear whether or not previously built prediction models are still sufficiently effective. Methods: We developed a machine learning (XGBoost) model to predict during the incubation period a SARS-CoV-2 infection that is subsequently diagnosed after 3 or more days. We used data from multiple sources, including demographic, clinical, treatment, laboratory, and vaccination information from a national network of hemodialysis clinics, socioeconomic information from the Census Bureau, and county-level COVID-19 infection and mortality information from state and local health agencies. We created prediction models and evaluated their performances on a rolling basis to investigate the evolution of prediction power and risk factors. Result: From April 2020 to August 2020, our machine learning model achieved an area under the receiver operating characteristic curve (AUROC) of 0.75, an improvement of over 0.07 from a previously developed machine learning model published by Kidney360 in 2021. As the pandemic evolved, the prediction performance deteriorated and fluctuated more, with the lowest AUROC of 0.6 in December 2021 and January 2022. Over the whole study period, that is, from April 2020 to February 2022, fixing the false-positive rate at 20%, our model was able to detect 40% of the positive patients. We found that features derived from local infection information reported by the Centers for Disease Control and Prevention (CDC) were the most important predictors, and vaccination status was a useful predictor as well. Whether or not a patient lives in a nursing home was an effective predictor before vaccination, but became less predictive after vaccination. Conclusion: As found in our study, the dynamics of the prediction model are frequently changing as the pandemic evolves. County-level infection information and vaccination information are crucial for the success of early COVID-19 prediction models. Our results show that the proposed model can effectively identify SARS-CoV-2 infections during the incubation period. Prospective studies are warranted to explore the application of such prediction models in daily clinical practice.

Indexed as

COVID-19hemodialysismachine learningpredictionXGBoost

Identifiers

PMID37675373
PMCPMC10479652
OpenAlexW4379230594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.